Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11

Fig. 1

The expression of MiR-7-5p is low in the peripheral blood of AML patients and AML cell lines. A The expressing of miR-7-5p was remarkably reduced in the peripheral blood of AML sufferers (n = 60) compared with that of the Normal Controls (NC) (n = 60). **p < 0.01 in contrast to NC. B MiR-7-5p expressing in human normal hematopoietic cell GM12878 (a) and the AML cell lines MOLM13 (b), THP1 (c), U937 (d), HL60 (e), MV4-11 (f) and KG-1 (g). *p < 0.05 compared with GM12878. C ROC curve analysis revealed that miR-7-5p was an underlying marker for screening AML patients from healthy controls. D Correlation of the peripheral blood miR-7-5p level with clinical characteristics of 60 AML patients

Back to article page